Journey from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases.

Simple item page
dc.contributor.authorAleem Khan, Aen_US
dc.contributor.authorParveen, Nen_US
dc.contributor.authorHabeeb, M Aen_US
dc.contributor.authorHabibullah, C Men_US
dc.date.accessioned2006-05-29en_US
dc.date.accessioned2009-05-27T06:46:33Z
dc.date.available2006-05-29en_US
dc.date.available2009-05-27T06:46:33Z
dc.date.issued2006-05-29en_US
dc.description70 references.en_US
dc.description.abstractAcute liver failure (ALF) carries high morbidity and mortality (>80%) even in the best centres. Orthotopic liver transplantation (OLTx) is the only viable approach to the treatment of ALF. This has significantly improved the survival in these patients. The major limitations of OLTx are non availability of the donor liver, requirement of a major surgical procedure, high cost and longterm immunosuppression. Isolated hepatocyte transplantation is emerging as an appealing method for the treatment of ALF because of its technical simplicity and easy availability of cells. Transplantation of allogenic/xenogenic hepatocytes transplantation in experimentally induced ALF has shown an increased survival rate. Clinical studies in acute, chronic liver failure and metabolic disorders have also been undertaken in a few centres and have shown encouraging results. To maintain the continuous supply of cells, xenogenic source of hepatocytes (porcine, rabbit, canine) have offered a hope. A major concern regarding the use of xenogenic donors is the risk of transmission of zoonosis and immunogenicity. Recently, Porcine endogenous retrovirus (PERV) has been shown to infect human tissue in vitro. The problem of immunogenicity of xenogenic hepatocytes can be overcome to some extent by immunoisolation, encapsulation technique, which may also provide protection to the hepatocytes during cryopreservation. The knowledge of adult hepatic stem from tissue offered a new hope for the treatment of various chronic and metabolic diseases. Further, the transdifferentiation potentiality of haematopoietic stem cells to hepatic lineage has strengthened cell therapy.en_US
dc.description.affiliationCentre for Liver Research and Diagnostics, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, Hyderabad, India.en_US
dc.identifier.citationAleem Khan A, Parveen N, Habeeb MA, Habibullah CM. Journey from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases. Indian Journal of Medical Research. 2006 May; 123(5): 601-14en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/17854
dc.language.isoengen_US
dc.source.urihttps://icmr.nic.in/ijmr/ijmr.htmen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAntibodies, Heterophileen_US
dc.subject.meshArtificial Organsen_US
dc.subject.meshCell Separationen_US
dc.subject.meshHepatocytes --immunologyen_US
dc.subject.meshHumansen_US
dc.subject.meshLiver Diseases --therapyen_US
dc.subject.meshLiver Failure --therapyen_US
dc.subject.meshLiver Transplantationen_US
dc.subject.meshMiceen_US
dc.subject.meshRatsen_US
dc.subject.meshStem Cell Transplantationen_US
dc.subject.meshTransplantation, Heterologousen_US
dc.subject.meshTransplantation, Homologousen_US
dc.subject.meshTrisaccharidesen_US
dc.subject.meshUltraviolet Raysen_US
dc.titleJourney from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Medical Research